Skip to content

EMIT C-Reactive Protein Assay

by Syva Co. 510(k)

Active United States

510(k) K821413

Overview

The EMIT C-Reactive Protein Assay is an enzyme-multiplied immunoassay designed for the quantitative measurement of C-reactive protein (CRP) in human serum or plasma. CRP is a blood protein that rises in response to inflammation, infection, or tissue injury, making this assay useful for monitoring inflammatory conditions and assessing disease activity in clinical settings.

This assay is intended for use in clinical laboratories equipped with appropriate instrumentation, such as the EMIT system. Supplied as a reagent kit, it requires no sterilization as it is designed for single-use per test. The device is classified under FDA 510(k) clearance (K821413) with a decision date of May 28, 1982, and falls under product code DCN for C-reactive protein systems. No MRI safety or reusable components are specified in the regulatory data.

AI-generated from registry data, 1 Oct 2026.Not verified by deviCERTS or the manufacturer

Regulatory status

as of 28 Oct 2026

RegionAuthorizationNumberDateStatus
United StatesFDA 510(k)SESE Substantially Equivalent · Traditional NumberK821413 Date28 May 1982ClearedStatusActive

Coverage

1 jurisdiction

United States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of America
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not known
  • Not covered

United States — FDA 510(k) Active

Recalls

0 recalls · FDA

No FDA recalls on record, checked 22 Oct 2026.

Specification

510(k)

510(k) Number
FDA Product Code
DCN
Device Class
Class II
Regulation
21 CFR Part 866.5270
Advisory Committee
Immunology
FDA Decision
SESE Substantially Equivalent

Other devices from Syva Co.

See all devices from Syva Co. →

Questions

  • What is the EMIT C-Reactive Protein Assay used for?

    The EMIT C-Reactive Protein Assay is designed for the quantitative measurement of C-reactive protein (CRP) in human serum or plasma. CRP levels rise in response to inflammation, infection, or tissue injury, making this assay useful for monitoring inflammatory conditions and assessing disease activity in clinical settings. It helps clinicians evaluate patient responses to treatment and track progression of inflammatory diseases.

  • How is the EMIT C-Reactive Protein Assay supplied, and is it reusable?

    The EMIT C-Reactive Protein Assay is supplied as a reagent kit. It is intended for single-use per test and does not require sterilization. The kit is specifically designed for use with the EMIT system in clinical laboratories, ensuring compatibility and accuracy for quantitative CRP measurements.

  • Does the EMIT C-Reactive Protein Assay require any special handling or storage?

    The EMIT C-Reactive Protein Assay is supplied as a reagent kit for single-use tests, so no special sterilization or reuse procedures are required. While specific storage conditions are not detailed in the regulatory data, reagent kits like this are typically stored at controlled room temperature (15–30°C) away from direct light and moisture to maintain stability and accuracy. Always follow the manufacturer’s instructions for optimal performance.

  • What type of clinical laboratories can use the EMIT C-Reactive Protein Assay?

    The EMIT C-Reactive Protein Assay is intended for use in clinical laboratories equipped with the EMIT system, which is designed for immunoassay testing. Laboratories must ensure they have the appropriate instrumentation and trained personnel to operate the system and interpret results accurately. This assay is classified under FDA product code DCN for C-reactive protein systems.

  • Is there any regulatory approval or classification for the EMIT C-Reactive Protein Assay?

    The EMIT C-Reactive Protein Assay holds FDA 510(k) clearance with the classification of 'Substantially Equivalent' under the Immunology advisory committee. The clearance number is K821413, and the decision date was May 28, 1982. This classification indicates that the device meets regulatory standards for safety and effectiveness as determined by the FDA.